Figure 3.
Patients with stage IV Hodgkin lymphoma with complete response (CR) to varlilumab. PR, partial response; SD, stable disease.

Patients with stage IV Hodgkin lymphoma with complete response (CR) to varlilumab. PR, partial response; SD, stable disease.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal